Drugs / Natural Calculus Bovis
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07080632 | Oct 2025 → Mar 2026 overdue | intracerebral hemorrhage | Tongji Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Natural Calculus Bovis | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07080632 ↗ |
| Known as | NCB | “Natural Calculus Bovis(NCB)” NCT07080632 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “According to historical Chinese medical documents, bezoar possesses properties that can help prevent seizures, treat strokes, enhance cognitive function and mental well-being,...” NCT07080632 ↗ |
| Route | Oral | “Subjects will orally receive 300mg NCB per day from day 1 to day 7” NCT07080632 ↗ |